Dr Kasuya Hideki has graduated from medical career on 1990 at Aichi Medical University, Japan. He did his residency in general surgery, transplantation surgery and liver-pancreas surgery in Nagoya University, Japan. He also has experience in research including research fellowship at the division of surgical oncology at Massachusetts General Hospital, Harvard Medical School. Since then he is being involved in clinical as well as research work with focus on oncolytic virus, including its use, its generation and combination therapies with current approved therapies. In 2015, he started the laboratory of cancer immune therapy research center at Nagoya University as Chairman where he continues to do research on oncolytic virus and its use on pancreatic cancer. Dr Itzel Bustos Villalobos has graduated from medical career on 2002 from La Salle University, Mexico. She did internship in pediatrics and completed her PhD in pediatric oncology at the University of Nagoya, Japan. Posteriorly she did research in melanoma at the University of California, Davis with a broad experience in cancer immunology. Currently she works for the University of Nagoya at the Cancer Immune Therapy Research Center where she continues doing research on oncolytic virus in diverse types of cancer.